Shareholder Alert: Ademi LLP investigates whether Imago BioSciences, Inc. has obtained a Fair Price in its transaction with Merck

Provided By PR Newswire

Last update: Nov 21, 2022

MILWAUKEE, Nov. 21, 2022 /PRNewswire/ -- Ademi LLP is investigating Imago (Nasdaq: IMGO) for possible breaches of fiduciary duty and other violations of law in its transaction with Merck.